Gene · 57794
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis. | Chin Med J (Engl) | 2022 | 35864596 | PubTator, text mining | PubMed |
| Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export. | Cell Rep | 2022 | 35858577 | PubTator, text mining | PubMed |
| Stress-induced perturbations in intracellular amino acids reprogram mRNA translation in osmoadaptation independently of the ISR. | Cell Rep | 2022 | 35858571 | PubTator, text mining | PubMed |
| Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review). | Oncol Rep | 2022 | 35856447 | PubTator, text mining | PubMed |
| The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily Orthoparamyxovirinae. | Virus Evol | 2022 | 35854826 | PubTator, text mining | PubMed |
| circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway. | BMC Cancer | 2022 | 35854245 | PubTator, text mining | PubMed |
| RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis. | Signal Transduct Target Ther | 2022 | 35853866 | PubTator, text mining | PubMed |
| The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5. | Cell Death Discov | 2022 | 35853859 | PubTator, text mining | PubMed |
| HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression. | Cancer Sci | 2022 | 35848884 | PubTator, text mining | PubMed |
| Roles of circRNAs in hematological malignancies. | Biomark Res | 2022 | 35840998 | PubTator, text mining | PubMed |
| m6A-modified circRNAs: detections, mechanisms, and prospects in cancers. | Mol Med | 2022 | 35836125 | PubTator, text mining | PubMed |
| Identification of the ferroptosis-related ceRNA network related to prognosis and tumor immunity for gastric cancer. | Aging (Albany NY) | 2022 | 35835721 | PubTator, text mining | PubMed |
| The PreQ-20 TRIAL: A prospective cohort study of the oncologic safety, quality of life and cosmetic outcomes of patients undergoing prepectoral breast reconstruction. | PLoS One | 2022 | 35834508 | PubTator, text mining | PubMed |
| A transfer learning approach for reaction discovery in small data situations using generative model. | iScience | 2022 | 35832891 | PubTator, text mining | PubMed |
| A comparative analysis of machine learning classifiers for predicting protein-binding nucleotides in RNA sequences. | Comput Struct Biotechnol J | 2022 | 35832617 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| RNANetMotif: Identifying sequence-structure RNA network motifs in RNA-protein binding sites. | PLoS Comput Biol | 2022 | 35819951 | PubTator, text mining | PubMed |
| EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms. | Eur J Med Res | 2022 | 35818069 | PubTator, text mining | PubMed |
| Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One. | J Med Chem | 2022 | 35816671 | PubTator, text mining | PubMed |
| LINC00518 Promotes Cell Malignant Behaviors via Influencing EIF4A3-Mediated mRNA Stability of MITF in Melanoma. | Biomed Res Int | 2022 | 35813236 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57794/papers?page=62